Conference
Abstract 1424: Preclinical development of TAC01-CD19, a CD19 specific T-cell Antigen Coupler (TAC) therapy for the treatment of CD19-positive B cell malignancies
Authors
Helsen CW; Hayes D; Hammill J; Aarts C; Bader A; Rill D; Bramson J
Pagination
pp. 1424-1424
Publisher
American Association for Cancer Research (AACR)
Publication Date
July 1, 2019
DOI
10.1158/1538-7445.sabcs18-1424
Name of conference
Clinical Research (Excluding Clinical Trials)